Numinus Health Inc. has successfully completed its first extraction of psilocybe mushrooms. The achievement marks a major milestone for the company, as the successful extraction indicates a promising future for its medicinal mushroom-based products.
Psilocybe mushrooms are psychedelics, naturally occurring fungi with psychoactive compounds. They’ve been used for centuries in various cultural contexts, but are still met with stigma, especially in the western world.
However, Numinus’ groundbreaking extraction of the mushrooms offers the potential for medicinal use of the fungi. The process is designed to allow for the careful and accurate removal of the pharmacologically active compounds from the mushroom materials.
It suggests the possibility of developing new and safe therapies that are based on a form of the natural source.Preliminary studies have indicated numerous potential therapeutic benefits from these compounds, such as reducing depression, anxiety, and PTSD symptoms.
Numinus is currently in the process of developing new psychedelic-based therapies which will be available in 2021. Its primary focus is on treating addiction, but there are also programs in motion for mental health and end-of-life care.
The company is garnering international attention, as the completion of its first mushroom extraction paves the way for a safer, more efficacious, and less stigmatized approach to treating ailments. Its innovative processes pave the path for phytopharmaceuticals, which are expected to be game-changing within the healthcare field.
Numinus has already seen amazing success in its research, and will continue to improve its processes in order to offer a safe and effective approach to psychological and mental wellness. With its first successful mushroom extraction, the company is one step closer to creating a revolutionary form of healthcare.
Numinus Health Inc. has successfully completed its first extraction of psilocybe mushrooms. The achievement marks a major milestone for the company, as the successful extraction indicates a promising future for its medicinal mushroom-based products.
Psilocybe mushrooms are psychedelics, naturally occurring fungi with psychoactive compounds. They’ve been used for centuries in various cultural contexts, but are still met with stigma, especially in the western world.
However, Numinus’ groundbreaking extraction of the mushrooms offers the potential for medicinal use of the fungi. The process is designed to allow for the careful and accurate removal of the pharmacologically active compounds from the mushroom materials.
It suggests the possibility of developing new and safe therapies that are based on a form of the natural source.Preliminary studies have indicated numerous potential therapeutic benefits from these compounds, such as reducing depression, anxiety, and PTSD symptoms.
Numinus is currently in the process of developing new psychedelic-based therapies which will be available in 2021. Its primary focus is on treating addiction, but there are also programs in motion for mental health and end-of-life care.
The company is garnering international attention, as the completion of its first mushroom extraction paves the way for a safer, more efficacious, and less stigmatized approach to treating ailments. Its innovative processes pave the path for phytopharmaceuticals, which are expected to be game-changing within the healthcare field.
Numinus has already seen amazing success in its research, and will continue to improve its processes in order to offer a safe and effective approach to psychological and mental wellness. With its first successful mushroom extraction, the company is one step closer to creating a revolutionary form of healthcare.
